Jürgen Bukur

700 total citations
16 papers, 590 citations indexed

About

Jürgen Bukur is a scholar working on Immunology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jürgen Bukur has authored 16 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jürgen Bukur's work include Immunotherapy and Immune Responses (6 papers), Reproductive System and Pregnancy (4 papers) and Immune Cell Function and Interaction (3 papers). Jürgen Bukur is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Reproductive System and Pregnancy (4 papers) and Immune Cell Function and Interaction (3 papers). Jürgen Bukur collaborates with scholars based in Germany, United States and Switzerland. Jürgen Bukur's co-authors include Barbara Seliger, Rudolf Lichtenfels, Angelika Ackermann, Walburgis Brenner, Joachim Beck, Roland Kellner, Derek Atkins, Christoph Huber, Sebastian Melchior and Ingo Drexler and has published in prestigious journals such as Circulation, Cancer Research and Seminars in Cancer Biology.

In The Last Decade

Jürgen Bukur

15 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jürgen Bukur Germany 13 279 256 136 114 96 16 590
Angelita G. Utleg United States 10 441 1.6× 58 0.2× 76 0.6× 97 0.9× 95 1.0× 10 646
Runa Speer Germany 11 390 1.4× 80 0.3× 95 0.7× 58 0.5× 28 0.3× 15 569
Miroslava Janković Serbia 13 438 1.6× 290 1.1× 37 0.3× 85 0.7× 44 0.5× 46 596
Julie Hafner United States 16 424 1.5× 232 0.9× 138 1.0× 59 0.5× 18 0.2× 16 640
Yunee Kim Canada 10 389 1.4× 45 0.2× 57 0.4× 152 1.3× 156 1.6× 11 618
Michael L. Montpetit Canada 8 333 1.2× 156 0.6× 254 1.9× 77 0.7× 100 1.0× 10 694
Dorthe Gylling Crüger Denmark 15 275 1.0× 52 0.2× 185 1.4× 96 0.8× 54 0.6× 23 572
Terri Pustilnik United States 9 444 1.6× 529 2.1× 368 2.7× 75 0.7× 15 0.2× 12 1.1k
Vipul Bhargava United States 12 374 1.3× 237 0.9× 155 1.1× 93 0.8× 71 0.7× 21 672
Hideki Kuroda Japan 11 208 0.7× 92 0.4× 88 0.6× 42 0.4× 28 0.3× 30 594

Countries citing papers authored by Jürgen Bukur

Since Specialization
Citations

This map shows the geographic impact of Jürgen Bukur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jürgen Bukur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jürgen Bukur more than expected).

Fields of papers citing papers by Jürgen Bukur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jürgen Bukur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jürgen Bukur. The network helps show where Jürgen Bukur may publish in the future.

Co-authorship network of co-authors of Jürgen Bukur

This figure shows the co-authorship network connecting the top 25 collaborators of Jürgen Bukur. A scholar is included among the top collaborators of Jürgen Bukur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jürgen Bukur. Jürgen Bukur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Wickenhauser, Claudia, Daniel Bethmann, Matthias Kappler, et al.. (2021). Tumor Microenvironment, HLA Class I and APM Expression in HPV-Negative Oral Squamous Cell Carcinoma. Cancers. 13(4). 620–620. 15 indexed citations
2.
Meyer, Stefanie, Diana Handke, Anja Müeller, et al.. (2021). Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant Melanoma. Cancers. 13(15). 3907–3907. 7 indexed citations
3.
Bukur, Jürgen, Yonas Bekuretsion, Mathewos Assefa, et al.. (2020). Abstract B020: Antiproliferative efficacy of different targeted drugs on breast cancer cell lines of distinct subtypes. Cancer Epidemiology Biomarkers & Prevention. 29(6_Supplement_1). B020–B020.
4.
Friedrich, Michael, Simon Jasinski‐Bergner, Chiara Massa, et al.. (2019). Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy. Cancer Immunology Immunotherapy. 68(10). 1689–1700. 62 indexed citations
5.
Lennicke, Claudia, Jette Rahn, Jürgen Bukur, et al.. (2016). Modulation of MHC class I surface expression in B16F10 melanoma cells by methylseleninic acid. OncoImmunology. 6(6). e1259049–e1259049. 22 indexed citations
6.
Steven, André, Chiara Massa, Manuela Iezzi, et al.. (2013). HER-2/neu Mediates Oncogenic Transformation via Altered CREB Expression and Function. Molecular Cancer Research. 11(11). 1462–1477. 30 indexed citations
7.
Ruß, Martin, Barbara Seliger, Steffen Hauptmann, et al.. (2008). Abstract 5261: Platelet-Depletion Ameliorates Cardiac Function and Disease Severity in Experimental Autoimmune Myocarditis. Circulation. 118(suppl_18). 2 indexed citations
8.
Seliger, Barbara, Rudolf Lichtenfels, Derek Atkins, et al.. (2005). Identification of fatty acid binding proteins as markers associated with the initiation and/or progression of renal cell carcinoma. PROTEOMICS. 5(10). 2631–2640. 36 indexed citations
9.
Wang, Ena, Rudolf Lichtenfels, Jürgen Bukur, et al.. (2004). Ontogeny and Oncogenesis Balance the Transcriptional Profile of Renal Cell Cancer. Cancer Research. 64(20). 7279–7287. 23 indexed citations
10.
Bukur, Jürgen, Vera Rebmann, Hans Grosse‐Wilde, et al.. (2003). Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.. mediaTUM (Technical University of Munich). 63(14). 4107–11. 121 indexed citations
11.
Seliger, Barbara, Rudolf Lichtenfels, Derek Atkins, et al.. (2003). Identification of markers for the selection of patients undergoing renal cell carcinoma‐specific immunotherapy. PROTEOMICS. 3(6). 979–990. 39 indexed citations
12.
Bukur, Jürgen & Barbara Seliger. (2003). The role of HLA-G for protection of human renal cell–carcinoma cells from immune-mediated lysis: implications for immunotherapies. Seminars in Cancer Biology. 13(5). 353–359. 16 indexed citations
13.
Lichtenfels, Rudolf, Roland Kellner, Derek Atkins, et al.. (2003). Identification of metabolic enzymes in renal cell carcinoma utilizing PROTEOMEX analyses. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1646(1-2). 21–31. 74 indexed citations
14.
Bukur, Jürgen, et al.. (2003). Altered expression of nonclassical HLA class Ib antigens in human renal cell carcinoma and its association with impaired immune response. Human Immunology. 64(11). 1081–1092. 28 indexed citations
15.
Kellner, Roland, Rudolf Lichtenfels, Derek Atkins, et al.. (2002). Targeting of tumor associated antigens in renal cell carcinoma using proteome-based analysis and their clinical significance. PROTEOMICS. 2(12). 1743–1751. 63 indexed citations
16.
Lichtenfels, Rudolf, Roland Kellner, Jürgen Bukur, et al.. (2002). Heat shock protein expression and anti-heat shock protein reactivity in renal cell carcinoma. PROTEOMICS. 2(5). 561–570. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026